1 Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma Diseases of the Esophagus, April 30, 2013
2 A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer Annals of Oncology, April 19, 2013
3 Accuracy of Positron Emission Tomography/Computed Tomography in the Diagnosis and Restaging for Recurrent Ovarian Cancer: A Meta-Analysis International Journal of Gynecological Cancer, April 29, 2013 Evidence Based Medicine Review Article
4 Positron Emission Tomography/Computed Tomography for Diagnosis of Prosthetic Valve Endocarditis: Increased Valvular 18F-Fluorodeoxyglucose Uptake as a Novel Major Criterion JACC - Journal of the American College of Cardiology, April 19, 2013
5 Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm Langenbeck's Archives of Surgery, May 3, 2013
6 Evaluation of hypoxia in a feline model of head and neck cancer using 64Cu-ATSM positron emission tomography/computed tomography BMC Cancer, May 3, 2013
7 Oesophageal Chemoradiotherapy in the UK--Current Practice and Future Directions Clinical Oncology, May 10, 2013
8 FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer The Journal of Urology, May 6, 2013
9 A pilot study for the early assessment of the effects of BMS-754807 plus gefitinib in an H292 tumor model by [18F]fluorothymidine-positron emission tomography Investigational New Drugs, May 6, 2013
10 Value of 18F-FDG-PET/CT in detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: A comparative study with contrast enhanced ultrasound Journal of Digestive Diseases, May 7, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor